Skip to main content

Advertisement

SpringerLink
Log in

Coagulation tests show significant differences in patients with breast cancer

  • Research Article
  • Published:
Tumor Biology

Abstract

Activated coagulation and fibrinolytic system in cancer patients is associated with tumor stroma formation and metastasis in different cancer types. The aim of this study is to explore the correlation of blood coagulation assays for various clinicopathologic factors in breast cancer patients. A total of 123 female breast cancer patients were enrolled into the study. All the patients were treatment naïve. Pretreatment blood coagulation tests including PT, APTT, PTA, INR, D-dimer, fibrinogen levels, and platelet counts were evaluated. Median age of diagnosis was 51 years old (range 26–82). Twenty-two percent of the group consisted of metastatic breast cancer patients. The plasma level of all coagulation tests revealed statistically significant difference between patient and control group except for PT (p < 0.001 for all variables except for PT; p = 0.08). Elderly age (>50 years) was associated with higher D-dimer levels (p = 0.003). Metastatic patients exhibited significantly higher D-dimer values when compared with early breast cancer patients (p = 0.049). Advanced tumor stage (T3 and T4) was associated with higher INR (p = 0.05) and lower PTA (p = 0.025). In conclusion, coagulation tests show significant differences in patients with breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Falanga A, Rickles FR. Pathophysiology of the thrombophilic state in the cancer patient. Semin Thromb Haemost. 1999;25:173–82.

    Article  CAS  Google Scholar 

  2. Clahsen PC, van de Velde CJ, Julien JP, Floiras JL, Mignolet FY. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol. 1994;12:1266–71.

    CAS  PubMed  Google Scholar 

  3. Weiss RB, Tormey DC, Holland JF, Weinberg VE. Venous thrombosis during multimodal treatment of primary breast carcinoma. Cancer Treat Rep. 1981;65:677–9.

    CAS  PubMed  Google Scholar 

  4. Brown LF, Guidi AJ, Schnitt SJ, et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. Clin Cancer Res. 1999;5:1041–56.

    CAS  PubMed  Google Scholar 

  5. Dvorak HF. Thrombosis and cancer. Hum Pathol. 1987;18:275–84.

    Article  CAS  PubMed  Google Scholar 

  6. Miller B, Heilmann L. Hemorheologic variables in breast cancer patients at the time of diagnosis and during treatment. Cancer. 1988;62:350–4.

    Article  CAS  PubMed  Google Scholar 

  7. Ueno T, Toi M, Koike M, Nakamura S, Tominaga T. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer. 2000;83:164–70.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Falanga A, Levine MN, Consonni E, et al. The effect of very-low-dose warfarin on markers of hypercoagulation in metastatic breast cancer: results from a randomized trial. Thromb Haemost. 1998;79:23–7.

    CAS  PubMed  Google Scholar 

  9. Murray JJ. Coagulation and cancer. Br J Cancer. 1991;64:422–4.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Oya M, Akiyama Y, Yanagida T, Akao S, Ishikawa H. Plasma D-dimer level in patients with colorectal cancer: its role as a tumor marker. Surg Today. 1998;28:373–8.

    Article  CAS  PubMed  Google Scholar 

  11. den Ouden M, Ubachs JMH, Stoot JEGM, van Wersch JWJ. Thrombin-antithrombin III and D-dimer plasma levels with benign or malignant ovarian tumors. Scand J Clin Lab Invest. 1998;58:555–60.

    Article  Google Scholar 

  12. Dirix LY, Salgado R, Weytjens R, et al. Plasma fibrin D-dimer levels correlate with tumour volume, progression rate and survival in patients with metastatic breast cancer. Br J Cancer. 2002;86:389–95.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  13. McCulloch P, Douglas J, Lowe GD, Murray G, George WD. In vivo measurement of fibrin formation and fibrinolysis in operable breast cancer. Thromb Haemost. 1989;61:318–21.

    CAS  PubMed  Google Scholar 

  14. Mitter CG, Zielinski C. Plasma levels of D-dimer: a cross-linked fibrin-degradation product in female breast cancer. J Cancer Res Clin Oncol. 1991;117:259–62.

    Article  CAS  PubMed  Google Scholar 

  15. von Tempelhoff GF, Dietrich M, Hommel G, Heilmann L. Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with operable breast cancer. J Clin Oncol. 1996;14:2560–8.

    CAS  Google Scholar 

  16. Pereira H, Pinder SE, Sibbering DM, et al. Pathological prognostic factors in breast cancer. IV: should you be a typer or grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology. 1995;27:219–26.

    Article  CAS  PubMed  Google Scholar 

  17. Mayer M. Biochemical and biological aspects of the plasminogen activator system. Clin Biochem. 1990;23:197–211.

    Article  CAS  PubMed  Google Scholar 

  18. Schmitt M, Jänicke F, Moniwa N, et al. Tumor-associated urokinase-type plasminogen activator; biological and clinical significance. Biol Chem Hoppe Seyler. 1992;373:611–22.

    Article  CAS  PubMed  Google Scholar 

  19. Zorio E, Gilabert-Estellés J, Espaňa F, et al. Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem. 2008;15:923–9.

    Article  CAS  PubMed  Google Scholar 

  20. Kim HK, Song KS, Lee KR, et al. Comparison of plasma D-dimer and thrombus precursor in patients with operable breast cancer as a potential predictor of metastasis. Blood Coagul Fibrinolysis. 2004;15:9–13.

    Article  CAS  PubMed  Google Scholar 

  21. Oya M, Akiyama Y, Okuyama T, Ishikawa H. High preoperative plasma D-dimer level is associated with advanced tumor stage and short survival after curative resection in patients with colorectal cancer. Jpn J Clin Oncol. 2001;31:388–94.

    Article  CAS  PubMed  Google Scholar 

  22. Taguchi O, Gabazza EC, Yasui H, et al. Prognostic significance of plasma D-dimer levels in patient with lung cancer. Thorax. 1997;52:563–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Kirwan CC, McDowell G, McCollum CN, Kumar S, Byrne GJ. Early changes in the haemostatic and procoagulant systems after chemotherapy for breast cancer. Br J Cancer. 2008;99:1000–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Batschauer APB, Figueiredo CP, Bueno EC, et al. D-dimer as a possible prognostic marker of operable hormone receptor-negative breast cancer. Ann Oncol. 2010;21:1267–72.

    Article  CAS  PubMed  Google Scholar 

  25. Unsal E, Atalay F, Atikcan S, Yilmaz A. Prognostic significance of haemostatic parameters in patients with lung cancer. Respir Med. 2004;98:93–8.

    Article  PubMed  Google Scholar 

  26. Rella C, Coviello M, Frenza ND, et al. Plasma D-dimer measurement as a marker of gynecological tumors: comparison with CA 125. Tumori. 1993;79:347–51.

    CAS  PubMed  Google Scholar 

  27. Kilic M, Yoldas O, Keskek M, et al. Prognostic value of plasma D-dimer levels in patients with colorectal cancer. Colorectal Dis. 2008;10:238–41.

    Article  CAS  PubMed  Google Scholar 

  28. Blackwell K, Haroon Z, Broadwater G, et al. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status. J Clin Oncol. 2000;18:600–8.

    CAS  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Role of the funding source

None

Author information

Authors and Affiliations

  1. Institute of Oncology, University of Istanbul, Capa, 34390, Istanbul, Turkey

    Faruk Tas, Leyla Kilic & Derya Duranyildiz

Authors
  1. Faruk Tas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leyla Kilic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Derya Duranyildiz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Faruk Tas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tas, F., Kilic, L. & Duranyildiz, D. Coagulation tests show significant differences in patients with breast cancer. Tumor Biol. 35, 5985–5992 (2014). https://doi.org/10.1007/s13277-014-1793-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-014-1793-4

Keywords

Search

Navigation